Skip to main navigation
Skip to search
Skip to main content
Search All UT System Experts
University of Texas Southwestern Medical Center Home
Home
Profiles
Research units
Equipment
Research output
Search by expertise, name or affiliation
Paternal safety of anti-rheumatic medications
Bonnie L. Bermas
Internal Medicine
Rheumatic Diseases
Research output
:
Contribution to journal
›
Review article
›
peer-review
28
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Paternal safety of anti-rheumatic medications'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Paternal Exposure
100%
Cyclophosphamide
86%
Sulfasalazine
79%
Safety
71%
Rheumatic Diseases
65%
Fathers
60%
Fertility Agents
47%
Abatacept
43%
Interleukin 1 Receptor Antagonist Protein
41%
Fertility Preservation
41%
Hydroxychloroquine
41%
Mercaptopurine
41%
Azoospermia
39%
Thalidomide
38%
Semen Analysis
38%
Tumor Necrosis Factor Inhibitors
37%
Mycophenolic Acid
36%
Colchicine
35%
Intravenous Immunoglobulins
34%
Azathioprine
34%
Rituximab
33%
Non-Steroidal Anti-Inflammatory Agents
33%
Tacrolimus
33%
Pregnancy Outcome
31%
Disease Management
30%
Biological Products
30%
Methotrexate
29%
Cyclosporine
28%
Spermatozoa
28%
Infertility
28%
Glucocorticoids
28%
Immunosuppressive Agents
25%
Tumor Necrosis Factor-alpha
21%
Child
13%
Pharmaceutical Preparations
12%